Recombinant Tissue-Type Plasminogen Activator and Immediate Angioplasty in Acute Myocardial Infarction. One-Year Follow-Up. The European Cooperative Study Group [Published Errata Appear in Circulation 1993 May;87(5):1775 and 1993 Jun;87(6):2070]

Circulation - United States
doi 10.1161/01.cir.86.1.111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction.

BMJ
1988English

Ventricular Arrhythmias During Treatment With Alteplase (Recombinant Tissue Plasminogen Activator) in Suspected Acute Myocardial Infarction.

Heart
Cardiovascular MedicineCardiology
1991English

Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction: Authors' Reply

BMJ
1988English

Immediate Coronary Angioplasty for Acute Myocardial Infarction.

BMJ
1993English

Primary Angioplasty Versus Fibrinolysis in Acute Myocardial Infarction: Long-Term Follow-Up in the Danish Acute Myocardial Infarction 2 Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Intravenous and Intrapulmonary Recombinant Tissue-Type Plasminogen Activator in the Treatment of Acute Massive Pulmonary Embolism

Circulation
Cardiovascular MedicinePhysiologyCardiology
1988English

Recombinant Tissue Plasminogen Activator Prevents Intimal Hyperplasia After Balloon Angioplasty in Hypercholesterolemic Rabbits

Japanese Circulation Journal
1996English

Ambulatory Blood Pressure Monitoring in Patients With ST- Elevation Myocardial Infarction: One Year Follow-Up Study

International Journal of Research in Medical Sciences
2019English

Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?

Neurology International
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy